The race to build a useful quantum computer is heating up [...]
The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joins as new co-lead alongside Kurma Partners in a final close that brings the oversubscribed seed round to €17 million. Most drugs work by blocking proteins. They attach […]<br /> This story c [...]
Nvidia has been in talks to acquire Hugging Face at a valuation above $13bn, according to Business Insider, days after reports that the open-model hub was exploring a sale at roughly that figure. The Information puts the process further along than that, reporting an agreed deal at $12.9bn, and Nvidia did not respond to a request […]<br /> This story continues at The Next Web [...]